- Hepatic Fibrosis and Cancer: The Silent Threats of Metabolic Syndrome
-
Friedman SL
- KMID: 2553587
- Diabetes Metab J.
- 2024 Mar;48(2):161-169.
- doi: 10.4093/dmj.2023.0240
Metabolic dysfunction-associated steatotic (fatty) liver disease (MASLD), previously termed non-alcoholic fatty liver disease, is a worldwide epidemic that can lead to hepatic inflammation, fibrosis, cirrhosis, and hepatocellular carcinoma (HCC). The... -
- CITED
-
- Close
- SHARE
-
- Close
